AJP - Regulatory, Integrative and Comparative Physiology, Vol 269, Issue 2 229-R235, Copyright © 1995 by American Physiological Society

ARTICLES

Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6

I. Guillen, M. Blanes, M. J. Gomez-Lechon and J. V. Castell
Research Center, University Hospital La Fe, Valencia, Spain.

The purpose of this study was to investigate the significance of the sequential changes in proinflammatory cytokines observed in the plasma of patients early after myocardial infarct: a rise in interleukin (IL)-1 beta (308 +/- 126 vs. 141 +/- 78 pg/ml, P < 0.01) between 0 and 2 h followed by an IL-6 peak (49 +/- 24 vs. 14.5 +/- 13 pg/ml, P < 0.01) 4-9 h later. No significant changes in tumor necrosis factor-alpha (TNF-alpha) were observed at this early stage. The linkage between IL-1 beta and IL-6 secretions is supported by 1) the ability of patient's plasma drawn early after myocardial infarction to induce IL-6 mRNA and protein synthesis in cells that may be potential targets in vivo (fibroblasts and endothelial cells), 2) suppression of this activity by antibodies against IL-1 beta, and 3) a delay between IL-1 beta and IL-6 peaks in vivo (4-9 h), which is similar to the time required for maximal IL-6 production in IL-1 beta stimulated target cells in vitro (6 h). This sequential signaling might serve as the basis for an amplification mechanism of proinflammatory cytokines. In fact, a much greater synthesis of C-reactive protein was observed in hepatocytes when stimulated with conditioned medium of fibroblasts or endothelial cells that had previously been incubated with plasma of patients. The results of our work strongly suggest that, by inducing IL-6 in potential target cells, IL-1 beta could act as the primary, but indirect, signal that stimulates acute-phase protein synthesis after myocardial injury.

This article has been cited by other articles:

				X.-W. Yu, Q. Chen, R. H Kennedy, and S. J Liu Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes J. Physiol., July 15, 2005; 566(2): 327 - 340. [Abstract] [Full Text] [PDF]

				S. A. JONES, S. HORIUCHI, N. TOPLEY, N. YAMAMOTO, and G. M. FULLER The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J, January 1, 2001; 15(1): 43 - 58. [Abstract] [Full Text] [PDF]

				P. M. Ridker, N. Rifai, M. J. Stampfer, and C. H. Hennekens Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men Circulation, April 18, 2000; 101(15): 1767 - 1772. [Abstract] [Full Text] [PDF]

				N Nagaya, T Nishikimi, M Uematsu, Y Yoshitomi, Y Miyao, S Miyazaki, Y Goto, S Kojima, M Kuramochi, H Matsuo, et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction Heart, May 1, 1999; 81(5): 483 - 487. [Abstract] [Full Text]

				M. Gwechenberger, L. H. Mendoza, K. A. Youker, N. G. Frangogiannis, C. W. Smith, L. H. Michael, and M. L. Entman Cardiac Myocytes Produce Interleukin-6 in Culture and in Viable Border Zone of Reperfused Infarctions Circulation, February 2, 1999; 99(4): 546 - 551. [Abstract] [Full Text] [PDF]

				S. J. Liu, W. Zhou, and R. H. Kennedy Suppression of beta -adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H141 - H148. [Abstract] [Full Text] [PDF]

				P. Yue, B. M. Massie, P. C. Simpson, and C. S. Long Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H250 - H258. [Abstract] [Full Text] [PDF]

				K. Bhagat and P. Vallance Inflammatory Cytokines Impair Endothelium-Dependent Dilatation in Human Veins In Vivo Circulation, November 4, 1997; 96(9): 3042 - 3047. [Abstract] [Full Text]